Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Doctors have reported a rare neurological side effect linked to Lenvatinib, a targeted therapy for advanced kidney cancer, raising concerns about its safety profile. The case, published this week in ... Read More
Continuous Coverage
The Norwegian national football team’s staff were seen in tears following a defeat, according to Dagbladet. The result…
Indonesian disc jockey and performer DJ Una has officially confirmed her engagement to partner Andi Agum Djollo. Following…
On June 28, 2026, Australia’s annual sausage festival kicked off in Perth, drawing international attention to the country’s…
“An intense heat wave is sweeping across the central and eastern United States, with 111 million people under…
The AEW x NJPW Forbidden Door event is set for July 1, 2024, at 8:00 PM ET at…
The Southern Environmental Law Center has filed a lawsuit against the Tennessee Valley Authority (TVA) over plans to…
Global Affairs
The Australian government has introduced new visa restrictions targeting Chinese nationals suspected of involvement in “state-sponsored espionage or…
Markets And Money
As of June 28, 2026, gold prices in Egypt experienced a marginal recovery during midday trading following a…
Digital Culture
German physicist Max Planck, the 1918 Nobel Prize winner whose work laid the foundation for quantum mechanics, had…
Science And Wellbeing
Results from the HER2CLIMB-05 trial show tucatinib, when combined with trastuzumab and pertuzumab, extends progression-free survival in HER2-positive…
Screen And Sound
Swiss heptathlete Annik Kälin shattered the national record in Ratingen, Germany, late Tuesday night, securing a dominant victory…
Fixtures And Form
TNA Unveils Knockouts Television Championship and 16-Woman Tournament Amid Franchise Rebranding Efforts TNA Wrestling confirmed the introduction of…
